Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte F M Slangen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Cancer|January 10, 2018
Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriersMarline G Harmsen, Jurgen M J Piek, Johan Bulten, et al.
Journal of Medical Virology|June 15, 2013
Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesionsRogier J N T M Litjens, Wendy Theelen, Yvonne van de Pas, et al.
Human Pathology|January 21, 2014
The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3Rogier J N T M Litjens, Koen K Van de Vijver, Anton H N Hopman, et al.
British Journal of Cancer|July 28, 2023
Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide studyNoortje Pleunis, Anne-Floor W Pouwer, Maaike H M Oonk, et al.
British Journal of Cancer|October 19, 2016
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriersLeendert H Zaaijer, Helena C van Doorn, Marian J E Mourits, et al.
Cancers|June 13, 2025
Risk Factors for Wound Complications in Vulvar Cancer Surgery and Indications for Reconstructive SurgeryJustin J E Delahaije, Ephrahim E Jerry, Saskia Houterman, et al.
Journal for Immunotherapy of Cancer|November 2, 2022
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesionsZiena Abdulrahman, Natasja Hendriks, Arnold J Kruse, et al.
Journal of Gynecologic Oncology|April 1, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort studyEster P Olthof, Hans H B Wenzel, Marissa C van Maaren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 18, 2022
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter StudyNatasja Hendriks, Margot M Koeneman, Anna J M van de Sande, et al.
Insights Into Imaging|February 9, 2024
Diagnostic accuracy of MRI, CT, and [<sup>18</sup>F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer - a nationwide Dutch cohort studyEster P Olthof, Brenda J Bergink-Voorthuis, Hans H B Wenzel, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cancer|January 10, 2018
Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriersMarline G Harmsen, Jurgen M J Piek, Johan Bulten, et al.
Journal of Medical Virology|June 15, 2013
Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesionsRogier J N T M Litjens, Wendy Theelen, Yvonne van de Pas, et al.
Human Pathology|January 21, 2014
The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3Rogier J N T M Litjens, Koen K Van de Vijver, Anton H N Hopman, et al.
British Journal of Cancer|July 28, 2023
Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide studyNoortje Pleunis, Anne-Floor W Pouwer, Maaike H M Oonk, et al.
British Journal of Cancer|October 19, 2016
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriersLeendert H Zaaijer, Helena C van Doorn, Marian J E Mourits, et al.
Cancers|June 13, 2025
Risk Factors for Wound Complications in Vulvar Cancer Surgery and Indications for Reconstructive SurgeryJustin J E Delahaije, Ephrahim E Jerry, Saskia Houterman, et al.
Journal for Immunotherapy of Cancer|November 2, 2022
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesionsZiena Abdulrahman, Natasja Hendriks, Arnold J Kruse, et al.
Journal of Gynecologic Oncology|April 1, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort studyEster P Olthof, Hans H B Wenzel, Marissa C van Maaren, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 18, 2022
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter StudyNatasja Hendriks, Margot M Koeneman, Anna J M van de Sande, et al.
Insights Into Imaging|February 9, 2024
Diagnostic accuracy of MRI, CT, and [<sup>18</sup>F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer - a nationwide Dutch cohort studyEster P Olthof, Brenda J Bergink-Voorthuis, Hans H B Wenzel, et al.
Pageof 5